Подходы к диагностике и лечению гастроэзофагеальной рефлюксной болезни в сочетании с дуоденогастроэзофагеальным рефлюксом
- Авторы: Самсонов А.А.1, Голубев Н.Н.2, Андреев Н.Г.1, Одинцова А.Н.1
-
Учреждения:
- ГОУ ВПО “Московский государственный медико-стоматологический университет ” Минздравсоцразвития РФ
- клиника “Ниармедик”
- Выпуск: № 10 (2012)
- Страницы: 10-15
- Раздел: Статьи
- URL: https://journals.eco-vector.com/2073-4034/article/view/279607
- ID: 279607
Цитировать
Полный текст
Доступ предоставлен
Доступ платный или только для подписчиков
Аннотация
Полный текст
Об авторах
Алексей Андреевич Самсонов
ГОУ ВПО “Московский государственный медико-стоматологический университет ” Минздравсоцразвития РФ
Email: aleksey.samsonov@gmail.com
доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней и гастроэнтерологии
Николай Николаевич Голубев
клиника “Ниармедик”
Email: nngolubev@mail.ru
кандидат медицинских наук, врач-гастроэнтеролог и эндоскопист клиники
Николай Германович Андреев
ГОУ ВПО “Московский государственный медико-стоматологический университет ” Минздравсоцразвития РФкандидат медицинских наук, доцент кафедры пропедевтики внутренних болезней и гастроэнтерологии
Анастасия Николаевна Одинцова
ГОУ ВПО “Московский государственный медико-стоматологический университет ” Минздравсоцразвития РФкандидат медицинских наук, ассистент кафедры пропедевтики внутренних болезней и гастроэнтерологии
Список литературы
- Лазебник Л.Б., Машарова А.А., Бордин Д.С. и др. Многоцентровое исследование “Эпидемиология гастроэзофагеальной рефлюксной болезни в России (МЭГРЕ): первые итоги" // Эксперимент. и клин. гастроэнтерол. 2009. № 6. С. 4-12.
- Tack J. Review article: role of pepsin and bile in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2005;(1):48-54.
- Hershcovici T, Fass R. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors. Curr Opin Gastroenterol 2010;26(4):367-78.
- Orlando RC, Bozymski EM. Heartburn in pernicious anemia - a consequence of bile reflux. N Engl J Med 1973;289:522-23.
- Matikainen M, Laatikainen T, Kalima T, et al. Bile acid composition and esophagitis after total gastrectomy. Am J Surg 1982;143:196-98.
- Vaezi MF, Singh S, Richter JE. Role of acid and duodenogastric reflux in oesophageal mucosal injury: a review of animal and human studies. Gastroenterology 1995;108:1897-907.
- Farre R, Fornari F, Blondeau K, et al. Acid and weakly acidic solutions impair mucosal integrity of distal exposed and proximal non-exposed human oesophagus. Gut 2010;59:164-69.
- Bateson MC, Hopwood D, Milne G, Bouchier IA. Oesophageal epithelial ultrastructure after incubation with gastrointestinal fluids and their components. J Pathol 1981;133:33-51.
- Souza RF, Huo X, Mittal V, et al. Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology 2009;137:1776-84.
- McQuaid KR, Laine L, Fennerty MB, et al. Systematic review: the role of bile acids in the pathogenesis of gastro-oesophageal reflux disease and related neoplasia. Aliment Pharmacol Ther 2011;34:146-65.
- Hong J, Behar J, Wands J, et al. Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma. Gut 2010;59:170-80.
- Nehra D, Howell P, Williams CP, et al. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 1999;44:598-602.
- Sifrim D, Castell D, Dent J, Kahrilas PJ. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut 2004;53:1024-31.
- Boecxstaens V, Bisschops R, Blondeau K, et al. Modulation of the postprandial acid and bile pockets at the gastro-oesophageal junction by drugs that affect gastric motility. Aliment Pharmacol Ther 2011;33:1370-77.
- Boeckxstaens GE, Smout A. Systematic review: role of acid, weakly acidic and weakly alkaline reflux in gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2010;32:334-43.
- Champion G, Richter JE, Vaezi MF, et al. Duodeno-gastro-oesophageal reflux: relationship to pH and importance in Barrett's oesophagus. Gastroenterology 1994;107:747-54.
- Pace F, Sangaletti O, Pallotta S, et al. Biliary reflux and nonacid reflux are two distinct phenomena: a comparison between 24-h multichannel intra-esophageal impedance and bilirubin monitoring. Scand J Gastroenterol 2007;42:1031-39.
- Yumiba T, Kawahara H, Nishikawa K, et al. Impact of esophageal bile exposure on the genesis of reflux esophagitis in the absence of gastric acid after total gastrectomy. Am J Gastroenterol 2002;97:1647-52.
- Wilmer A, Tack J, Frans E, et al. Duodeno-gastro-oesophageal reflux and oesophageal mucosal injury in mechanically ventilated patients. Gastroenterology 1999;116:1293-99.
- Xu X, Li Z, Zou D, et al. Role of duodeno-gastroesophageal reflux in the pathogenesis of esophageal mucosal injury and gastroesophageal reflux symptoms. Can J Gastroenterol 2006;20(2):91-4.
- Tack J, Bisschops R, Koek G, et al. Dietary restrictions during ambulatory monitoring of duodeno-gastro-oesophageal reflux. Dig Dis Sci 2003;48:1213-30.
- Oh DS, Hagen JA, Fein M, et al. The impact of reflux composition on mucosal injury and esophageal function. Journal of Gastrointestinal Surgery 2005;10:87-797.
- Kunsch S, Neesse A, Huth J, et al. Increased duo-deno-gastro-esophageal reflux (DGER) in symptomatic GERD patients with a history of cholecystectomy. Z Gastroenterol 2009;47:744-48.
- Wolfgarten E, Putz B, Holscher AH, Bollschweiler E. Duodeno-gastric-esophageal reflux - what is pathologic? Comparison of patients with Barrett's esophagus and age-matched volunteers. J GastrointestSurg 2007;11:479-86.
- Koek GH, Sifrim D, Lerut T, et al. Multivariate analysis of the association of acid and duo-deno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus. Gut 2008;57:1056-64.
- Marshall RE, Anggiansah A, Owen WA, Owen WJ. The relationship between acid and bile reflux and symptoms in gastro-oesophageal reflux disease. Gut 1997;40:182-87.
- Koek GH, Tack J, Sifrim D, et al. The role of acid and duodenal gastro-oesophageal reflux in symptomatic GERD. Am J Gastroenterol 2001;96:2033-40.
- Hoffman I, Tertychnyy A, Ectors N, et al. Duodenogastro-Esophageal Reflux in Children with Refractory Gastro-Esophageal Reflux Disease. The Journal of Pediatrics 2007;151:307-11.
- Karamanolis G, Vanuytsel T, Sifrim D, et al. Yield of 24-hour esophageal pH and bilitec monitoring in patients with persisting symptoms on PPI therapy. Dig Dis Sci 2008;53:2387-93.
- Gasiorowska A, Navarro-Rodriguez T, Wendel C, et al. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily. Am J Gastroenterol 2009;104:2005-13.
- Hershcovici T, Jha LK, Cui HJ, et al. Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor. Alimentary Pharmacology & Therapeutics 2011;33:837-44.
- Tack J. Review article: the role of bile and pepsin in the pathophysiology and treatment of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2006;24(2):10-6.
- Huo X, Zhang HY, Zhang X, et al. Omeprazole Blocks Secretion of the Inflammatory Cytokine IL-8 in Esophageal Squamous Epithelial Cells Exposed to Acid and Bile Salts: A Potential AntiInflammatory Effect of PPIs Independent of Acid Inhibition. Abstract 1063 Presented at Digestive Disease Week, 2010.
- Marshall RE, Anggiansah A, Manifold DK, et al. Effect of omeprazole 20 mg twice daily on duo-denogastric and gastro-osophageal bile reflux in barrett's esophagus. Gut 1998;43:603-06.
- Netzer P, Gut A, Brundler R, et al. Influence of pantoprazole on oesophageal motility, and bile and acid reflux in patients with oesophagitis. Aliment Pharmacol Ther 2001;15:1375-84.
- Menges M, Muller M, Zeitz M. Increased acid and bile reflux in Barrett's esophagus compared to reflux esophagitis, and effect of proton pump inhibitor therapy. The Am J of Gastroenterol 2001;96:331-37.
- Todd JA, Basu KK, DeCaestecker JS. Normalization of oesophageal pH does not guarantee control of duodenogastro-oesophageal reflux in Barrett's oesophagus. Aliment Pharmacol Ther 2005;21:969-75.
- Буеверов А.О., Лапина Т.Л. Дуодено-гастроэзофагеальный рефлюкс как причина рефлюкс эзофагита // Фарматека 2006. № 1. С. 22-7.
- Ивашкин В.Т., Трухманов А.С. Современный подход к терапии гастроэзофагеальной рефлюксной болезни во врачебной практике // РМЖ 2003. № 2. С. 43-8.
- Pace F, Pallotta S, Casalini S, Porro GB. A review of rabeprazole in the treatment of acidre-lated diseases. Therapeutics and Clinical Risk Management 2007;3:363-79.
- Koek GH, Sifrim D, Lerut T, et al. The effect of the GABAb agonist baclofen in patients with symptoms and duodenogastro-esophageal reflux refractory to proton pump inhibitors. Gut 2003;10:1397-402.
- Scarpellini E, Vos R, Blondeau K, et al. The effects of itoprid on esophageal motility and lower esophageal sprinter function in man. Aliment Pharmacol Ther 2011;33:99-105.
- Лапина Т.Л., Картавенко И.М. Урсодео-ксихолевания кислота: влияние на слизистую оболочку верхних отделов желудочно-кишечного тракта // Росс. журн. гастроэнтерол., гепатол., колопроктол. 2007. № 6. С. 51-7.